{
 "PrintNo":"S4774","Session":2021,"Chamber":"SENATE","BillType":"Senate","Published":"2021-02-11T12:36:19.797817Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-02-11","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"SENATE"}
 ],
 "Sponsors":[
  {"ID":1495,"Name":"Elijah Reichlin-Melnick","Short":"REICHLIN-MELNICK"},
  {"ID":1230,"Name":"Robert Jackson","Short":"JACKSON"}
 ],
 "Title":"Relates to labeling prescription bottles of opioids",
 "Summary":"Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug and that such drug may cause depression and overdose.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3333, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to labeling prescription bottles of opioids",
 "SameAsPrintNo":"A6067-2021","PreviousVersions":["S6630-2019"]
}